Inventor · disambiguated record
Zachary Shriver
Also filed as: SHRIVER ZACHARY · SHRIVER ZACHARY H · Shriver Zachary Holmes
85 granted patents·43 pending applications·1,529 citations·filing 1999–2025
99Inventor score
Files withVISTERRA INC52MASSACHUSETTS INST TECHNOLOGY30MOMENTA PHARMACEUTICALS INC18SHRIVER ZACHARY8MYETTE JAMES R2
Top patents by PatentIndex Score
128 records- 0198US7247445B22-O sulfatase compositions and methods of hydrolyzing therewithMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Jul 24, 2007·64 cites·5 claims
- 0298US6597996B1Method for indentifying or characterizing properties of polymeric unitsMASSACHUSETTS INST TECHNOLOGY·Filed 2000·Granted Jul 22, 2003·133 cites·9 claims
- 0397US11136385B2Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody moleculeVISTERRA INC·Filed 2020·Granted Oct 5, 2021·4 cites·38 claims
- 0497US10954296B2Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGAVISTERRA INC·Filed 2020·Granted Mar 23, 2021·4 cites·51 claims
- 0597US9212217B2Antibody molecules to dengue virus and uses thereofVISTERRA INC·Filed 2015·Granted Dec 15, 2015·14 cites·21 claims
- 0697US7504247B22-O sulfatase compositions and methods of degradation therewithMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Mar 17, 2009·44 cites·32 claims
- 0797US7429474B22-O sulfatase compositions and methods of analyzing therewithMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Sep 30, 2008·44 cites·25 claims
- 0897US7399604B2Methods and products related to evaluating the quality of a polysaccharideMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Jul 15, 2008·46 cites·23 claims
- 0997US7396824B22-O sulfatase nucleic acid compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Jul 8, 2008·50 cites·20 claims
- 1097US7390633B2Methods for preparing low molecular weight heparin with modified heparinase IIIMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Jun 24, 2008·53 cites·11 claims
- 1197US7117100B2Method for the compositional analysis of polymersMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Oct 3, 2006·75 cites·6 claims
- 1297US7110889B2Method for identifying or characterizing properties of polymeric unitsMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Sep 19, 2006·74 cites·21 claims
- 1397US7083937B2Methods and products related to the analysis of polysaccaridesMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Aug 1, 2006·91 cites·36 claims
- 1497US6869789B2Heparinase III and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Mar 22, 2005·99 cites·10 claims
- 1596US10968270B2Antibody molecules to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2020·Granted Apr 6, 2021·3 cites·30 claims
- 1696US9365639B2Antibody molecules to dengue virus and uses thereofVISTERRA INC·Filed 2015·Granted Jun 14, 2016·9 cites·30 claims
- 1796US7560106B2Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewithMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Jul 14, 2009·48 cites·13 claims
- 1896US7270815B22-O sulfatase compositions and related methodsMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Sep 18, 2007·63 cites·9 claims
- 1996US7139666B2Method for identifying or characterizing properties of polymeric unitsMASSACHUSETTS INST TECHNOLOGY·Filed 2003·Granted Nov 21, 2006·62 cites·22 claims
- 2095US7585642B2Methods for evaluating the quality of a heparin sampleMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Sep 8, 2009·33 cites·20 claims
- 2195US7455986B2Heparinase III and methods of specifically cleaving therewithMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Nov 25, 2008·32 cites·9 claims
- 2295US7412332B1Method for analyzing polysaccharidesMASSACHUSETTS INST TECHNOLOGY·Filed 2000·Granted Aug 12, 2008·56 cites·23 claims
- 2394US7884187B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2010·Granted Feb 8, 2011·15 cites·14 claims
- 2494US7695711B2Δ 4,5 glycuronidase nucleic acid compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Apr 13, 2010·16 cites·8 claims
- 2593US10385123B2Antibody molecules to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2018·Granted Aug 20, 2019·8 cites·30 claims
- 2693US8877200B2HA binding agentsVISTERRA INC·Filed 2013·Granted Nov 4, 2014·17 cites·9 claims
- 2793US7575886B2Analysis of sulfated polysaccharidesMOMENTA PHARMACEUTICALS INC·Filed 2003·Granted Aug 18, 2009·68 cites·69 claims
- 2892US10800835B2HA binding agentsVISTERRA INC·Filed 2018·Granted Oct 13, 2020·4 cites·20 claims
- 2992US10155806B2Antibody molecules to dengue virus and uses thereofVISTERRA INC·Filed 2016·Granted Dec 18, 2018·4 cites·30 claims
- 3092US9096657B2HA binding agentsVISTERRA INC·Filed 2014·Granted Aug 4, 2015·13 cites·30 claims
- 3192US7951560B2Delta 4,5 glycuronidase compositions and methods related theretoMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Granted May 31, 2011·13 cites·18 claims
- 3291US9709567B2Compositions and methods for diagnosing and/or treating influenza infectionMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Jul 18, 2017·6 cites·5 claims
- 3391US7790466B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Sep 7, 2010·15 cites·8 claims
- 3491US2025066464A1Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (april)VISTERRA INC·Filed 2024·Application pending·0 cites
- 3590US8592142B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Nov 26, 2013·5 cites·19 claims
- 3690US8101733B1Methods of evaluating mixtures of polysaccharidesSHRIVER ZACHARY·Filed 2006·Granted Jan 24, 2012·9 cites·21 claims
- 3790US7687479B2Methods and producing low molecular weight heparinMASSACHUSETTS INST TECHNOLOGY·Filed 2006·Granted Mar 30, 2010·10 cites·50 claims
- 3889US11912781B2Humanized complement 5A receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2022·Granted Feb 27, 2024·1 cites·10 claims
- 3989US11230593B2Compositions and methods for treating and preventing influenzaVISTERRA INC·Filed 2020·Granted Jan 25, 2022·4 cites·20 claims
- 4089US2024425569A1Antibody molecules to dengue virus and uses thereofVISTERRA INC·Filed 2024·Application pending·0 cites
- 4188US11059883B2Antibody molecules to dengue virus and uses thereofVISTERRA INC·Filed 2018·Granted Jul 13, 2021·2 cites·30 claims
- 4288US10513553B2Compositions and methods for treating and preventing influenzaVISTERRA INC·Filed 2016·Granted Dec 24, 2019·6 cites·22 claims
- 4388US8076149B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingSHRIVER ZACHARY·Filed 2010·Granted Dec 13, 2011·7 cites·28 claims
- 4488US7816144B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2009·Granted Oct 19, 2010·10 cites·7 claims
- 4587US10981982B2Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2020·Granted Apr 20, 2021·1 cites·48 claims
- 4687US9969794B2HA binding agentsVISTERRA INC·Filed 2013·Granted May 15, 2018·7 cites·50 claims
- 4787US8921116B2Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetateMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·5 cites·7 claims
- 4887US7056504B1Rationally designed heparinases derived from heparinase I and IIMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Jun 6, 2006·80 cites·12 claims
- 4986US12297249B2Interleukin-2 agents and uses thereofVISTERRA INC·Filed 2024·Granted May 13, 2025·0 cites·13 claims
- 5086US12264203B2Humanized complement 5a receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2024·Granted Apr 1, 2025·0 cites·13 claims
Showing the top 50 of 128 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →